Boston Scientific (BSX) analyst forecast and price target
Analyst forecast
Consensus of 34 analyst ratings
Based on 12 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Truist Securities | Maintained | Buy | $51.00 from $57.00 | Oct 14, 2026 |
| Barclays | Initiated Coverage | Equal-Weight | $48.00 | Oct 7, 2026 |
| Citigroup | Maintained | Neutral | $48.00 from $50.00 | Oct 5, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $48.00 from $50.00 | Sep 24, 2026 |
| Oppenheimer | Maintained | Outperform | $65.00 from $85.00 | Sep 21, 2026 |
| Citigroup | Downgraded | Buy → Neutral | $50.00 from $57.00 | Sep 17, 2026 |
| BTIG | Maintained | Buy | $56.00 from $60.00 | Sep 9, 2026 |
| TD Cowen | Maintained | Buy | $56.00 | Aug 25, 2026 |
| Argus Research | Downgraded | Buy → Hold | — | Jul 31, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $50.00 from $55.00 | Jul 30, 2026 |
| Evercore ISI Group | Maintained | Outperform | $55.00 from $65.00 | Jul 30, 2026 |
| Truist Securities | Maintained | Buy | $57.00 from $62.00 | Jul 30, 2026 |
| Canaccord Genuity | Maintained | Buy | $66.00 from $70.00 | Jul 30, 2026 |
| TD Cowen | Maintained | Buy | $56.00 from $61.00 | Jul 30, 2026 |
| RBC Capital | Maintained | Outperform | $70.00 from $85.00 | Jul 30, 2026 |
| Citigroup | Maintained | Buy | $61.00 from $70.00 | Jul 30, 2026 |
| UBS | Maintained | Buy | $67.00 from $74.00 | Jul 30, 2026 |
| BTIG | Maintained | Buy | $60.00 from $65.00 | Jul 29, 2026 |
| UBS | Initiated Coverage | Buy | $74.00 from $95.00 | Jul 28, 2026 |
| Oppenheimer | Maintained | Outperform | $85.00 from $90.00 | Jul 27, 2026 |
Frequently asked questions
What is the price target for BSX stock?
The average 12-month analyst price target for Boston Scientific (BSX) is $58.33, with a high estimate of $70.00 and a low of $48.00, across 12 analysts.
Is BSX a buy, sell, or hold?
Analysts covering Boston Scientific currently average a Buy rating: 27 buy, 7 hold and 0 sell, from 34 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for BSX?
The average price target of $58.33 implies 35.66% upside from the last price of $43.00.
What is the latest analyst rating on BSX?
On Oct 14, 2026, Truist Securities maintained Boston Scientific at Buy with a price target of $51.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.